THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 119 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $558,000 | -28.9% | 38,459 | 0.0% | 0.01% | -37.5% |
Q1 2021 | $785,000 | +8.6% | 38,459 | -5.4% | 0.01% | +14.3% |
Q4 2020 | $723,000 | +20.3% | 40,660 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $601,000 | +22.7% | 40,660 | +74.2% | 0.01% | +16.7% |
Q2 2020 | $490,000 | -9.1% | 23,344 | 0.0% | 0.01% | -25.0% |
Q1 2020 | $539,000 | +3.5% | 23,344 | +16.1% | 0.01% | +33.3% |
Q4 2019 | $521,000 | – | 20,106 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madison Avenue Partners, LP | 8,511,350 | $72,176,248 | 9.12% |
Newtyn Management, LLC | 2,124,703 | $18,017,481 | 3.38% |
Irenic Capital Management LP | 2,760,948 | $23,412,839 | 2.86% |
Weiss Asset Management LP | 7,457,060 | $63,235,869 | 2.39% |
Oasis Management Co Ltd. | 1,157,965 | $9,819,543 | 2.21% |
Park West Asset Management LLC | 1,700,000 | $14,416,000 | 1.06% |
Baupost Group | 4,200,021 | $35,616 | 0.98% |
Camber Capital Management LP | 1,000,000 | $8,480 | 0.24% |
Virtus ETF Advisers LLC | 38,386 | $325,513 | 0.16% |
GSA CAPITAL PARTNERS LLP | 204,089 | $1,731 | 0.12% |